Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness and safety of tapentadol
immediate release (IR) as compared with placebo and oxycodone IR in patients with acute pain
caused by vertebral compression fractures (VCF) associated with assumed osteoporosis for whom
treatment with oral opioid analgesics is appropriate.